Optimization of Fc-mediated effector functions of monoclonal antibodies
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 20 (6) , 685-691
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Structure of the Murine Unglycosylated IgG1 Fc FragmentJournal of Molecular Biology, 2009
- Structural characterization of a human Fc fragment engineered for extended serum half-lifeMolecular Immunology, 2009
- Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human bloodBMC Cancer, 2009
- Aglycosylated immunoglobulin G1variants productively engage activating Fc receptorsProceedings of the National Academy of Sciences, 2008
- Identification of a receptor required for the anti-inflammatory activity of IVIGProceedings of the National Academy of Sciences, 2008
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 2008
- Structural characterization of a mutated, ADCC-enhanced human Fc fragmentMolecular Immunology, 2008
- Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuriaNature Biotechnology, 2007
- The antiinflammatory activity of IgG: the intravenous IgG paradoxJournal of Experimental Medicine, 2007
- Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levelsNature Biotechnology, 2005